How Synthetic CBD Is Offering New Hope for Hard-to-Treat Epilepsy

When standard medications stop working, patients and families look for relief anywhere they can. This new study suggests a promising, more affordable option may already be here.

If you’ve ever known someone living with epilepsy, you’ve seen how unpredictable it can be. For many people living with epilepsy, managing seizures means taking daily medication and hoping it’s enough to keep life predictable. But for some, even the strongest drugs fall short. These are the patients doctors call “drug-resistant,” and their condition can feel like a maze with no way out.

That’s why a team of researchers in Germany set out to test something new – a synthetic form of cannabidiol (CBD). CBD has already gained attention for its role in reducing seizures, but nearly all previous studies used CBD extracted from plants. 

The question was: could a lab-made version work just as well?

Science Snapshot

• Focus: Lab-developed CBD for hard-to-treat epilepsy
• Participants: 35 patients (children to adults)
• Findings: Seizures reduced by about 40% after three months
• Tolerance: Mostly mild side effects; long-term use possible

The Challenge of Drug-Resistant Epilepsy

Epilepsy affects more than 50 million people worldwide, and while modern medications help many, roughly one in three patients continues to experience uncontrolled seizures. This condition, known as pharmacoresistant epilepsy, can make even basic daily activities risky and unpredictable.

CBD, or cannabidiol, has already shown promise for severe childhood epilepsies like Dravet and Lennox–Gastaut syndromes. But until recently, nearly all studies focused on plant-derived CBD—raising questions about consistency, cost, and sustainability.

That’s where the team at the University of Freiburg in Germany stepped in. They wanted to know: could synthetic CBD, created under precise laboratory conditions, provide the same results?

Inside the Study

Between 2017 and 2019, neurologists Kerstin Klotz, Daniel Grob, Martin Hirsch, Birgitta Metternich, Andreas Schulze-Bonhage, and Julia Jacobs conducted a detailed clinical trial involving 35 patients who had not responded to standard epilepsy medications.

Each participant received synthetic CBD alongside their regular treatment. The dosage started small, about 5 mg per kilogram per day, and was gradually increased to a maximum of 50 mg/kg/day to find the optimal level for each person.

The goal? To track whether seizure frequency decreased over the next three months and to assess how well patients tolerated the new compound.

What Happened When Patients Took Synthetic CBD

The results were nothing short of encouraging. After three months of treatment:

• Seizure frequency dropped by an average of 40%. Patients went from a median of about 22 seizures per month to just 8.
  
• Most participants tolerated the treatment well. While mild side effects like sleepiness, diarrhea, and appetite loss were reported, only 2 out of 35 patients discontinued treatment because of them.
  
• Many continued using the therapy long-term. Over half of the participants stayed on synthetic CBD for more than a year—proof that it wasn’t just effective but sustainable for daily life.

Even more notable? These improvements were consistent with previous studies on natural CBD, meaning synthetic versions could match their performance.

Why Synthetic CBD Matters

Creating CBD in a lab might sound strange, but it’s actually a breakthrough in both medicine and sustainability.

Here’s why it’s important:

• Consistency: Every batch of synthetic CBD is chemically identical, ensuring patients receive precise, predictable doses.
  
• Accessibility: Lab-made CBD could lower costs and reduce dependence on large-scale plant cultivation.
  
• Environmental benefits: No farming, extraction, or agricultural resources needed—just science doing what nature started.

In short, this innovation means more people could access high-quality CBD treatments in the future—safely, affordably, and sustainably.

What This Means for You

When medications stop working, daily life can feel unpredictable and exhausting. This research explored whether a lab-developed form of CBD could bring stability where other treatments had failed and for many, it did.

Here’s what that means in simple terms:

• Gentle relief: The compound reduced seizure frequency without major side effects.
• Consistency and safety: Because it’s lab-made, every dose is pure and identical, offering predictable results.
• Accessibility: It can be produced sustainably, making it more widely available for future care.
• Emotional impact: Fewer seizures don’t just mean medical improvement—they mean peace of mind, better sleep, and the chance to plan life again.

While larger studies are still needed, these findings offer something steady and meaningful: progress rooted in care and compassion, not hype.

---

Original Study Details:
Title: Efficacy and Tolerance of Synthetic Cannabidiol for Treatment of Drug-Resistant Epilepsy
Date: December 2019
Authors: Kerstin A. Klotz; Daniel Grob; Martin Hirsch; Birgitta Metternich; Andreas Schulze-Bonhage; Julia Jacobs
Link to Original Study: Frontiers

---